XyloCor Therapeutics Completes Phase 2 of EXACT Clinical Trial
WAYNE, PA — XyloCor Therapeutics announced the recent completion of the Phase 2 portion of its Phase 1/2 clinical trial (EXACT) designed to assess the safety and preliminary evidence of …
XyloCor Therapeutics Completes Phase 2 of EXACT Clinical Trial Read More